Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy

Conditions:   C3 Glomerulopathy;   Membranoproliferative Glomerulonephritis;   Complement Abnormality;   Dense Deposit Disease;   C3 Glomerulonephritis Interventions:   Drug: Aliskiren;   Drug: Enalapril Sponsor:   Region Skane Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials